| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Nouri Alaleh | EVP, CLO, CORP. SEC. | C/O PROCEPT BIOROBOTICS CORPORATION, 150 BAYTECH DRIVE, SAN JOSE | /s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri | 12 Mar 2026 | 0001599418 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRCT | Common Stock | Sale | $79,320 | -3,098 | -2.7% | $25.60 | 111,166 | 10 Mar 2026 | Direct | F1, F2 |
| transaction | PRCT | Common Stock | Sale | $3,877 | -145 | -0.13% | $26.74 | 111,021 | 10 Mar 2026 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.11 to $25.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.365 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |